◆英語タイトル：BerryPharma AG - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C13471
◆発行会社（調査会社）：
MarketLine
◆発行日：2019年2月
◆ページ数：18
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：イタリア
◆産業分野：材料
◆販売価格オプション（消費税別）
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
MarketLine社の概要はこちらでご確認いただけます。
BerryPharma AG – Strategy, SWOT and Corporate Finance Report
Summary
BerryPharma AG – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
BerryPharma AG (BerryPharma), the trademark of Iprona AG, is a manufacturer and distributor of liquid and powdered polyphenol products. The company manufactures polyphenol fruit powders, polyphenol liquids, polyphenol extract powders of red berries, such as elderberries, blackcurrants, bilberries, chokeberries (aronia), and cranberries. BerryPharma also offers customized fruit extracts based on its client requirement. Its products are offered to a number of industries including food, beverages, healthcare, cosmetics and pharmaceuticals. Its cooperation includes the Universities in Giessen and Düsseldorf (Germany), the German Institute for Nutrition in Karlsruhe, the China Medical University in Taiwan, the Scottish Crop and Research Institute, the Charite in Berlin, and the Kuopio University in Finland. BerryPharma is headquartered in Lana, South Tyrol, Italy.
Scope
- Detailed information on BerryPharma AG required for business and competitor intelligence needs
- A study of the major internal and external factors affecting BerryPharma AG in the form of a SWOT analysis
- An in-depth view of the business model of BerryPharma AG including a breakdown and examination of key business segments
- Intelligence on BerryPharma AG’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about BerryPharma AG, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
- Gain understanding of BerryPharma AG and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess BerryPharma AG as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on BerryPharma AG’s business structure, strategy and prospects.
Table of Contents
Company Snapshot
Table of Contents
BerryPharma AG: Company Overview
BerryPharma AG: Overview and Key Facts
BerryPharma AG: Overview
BerryPharma AG: Key Facts
BerryPharma AG: Major Products and Services
BerryPharma AG: Company History
BerryPharma AG: Locations and Subsidiaries
BerryPharma AG: Key Competitors
BerryPharma AG: Company Analysis
BerryPharma AG: Business Description
BerryPharma AG: SWOT Analysis
BerryPharma AG: SWOT Overview
BerryPharma AG: Strengths
BerryPharma AG: Weaknesses
BerryPharma AG: Opportunities
BerryPharma AG: Threats
Appendix
Contact Us
Methodology
About MarketLine
List of Tables
Table 1: BerryPharma AG: Key Facts
Table 2: BerryPharma AG: Company History
Table 3: BerryPharma AG: Locations and Subsidiaries
Table 4: BerryPharma AG: Key Competitors
